Skip to main content

Gannon Steven

In the past year, 1 open-market sale filing worth $640.5K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$640.5K
1 filing
Net
−$640.5K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Gannon Steven as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

XENE Xenon Pharmaceuticals Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 13, 2026 (view filing)4:33 PM ETAug 112 daysGannon StevenDirectorSSale−10.0K$64.06−$640.5K−84.2%1.87K after
Jun 6, 2025 (view filing)Jun 51 dayGannon StevenDirectorSSale−3$30.48−$91.440.0%7.14K after
Mar 8, 2024 (view filing)Mar 71 dayGannon StevenDirectorSSale−13.0K$46.28−$601.6K−86.7%2.00K after4 lots

FUSN Fusion Pharmaceuticals Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 11, 2022 (view filing)Aug 11Same dayGannon StevenDirectorPPurchase+44.4K$2.03+$90.1K+370.0%56.4K after
Aug 23, 2021 (view filing)Aug 23Same dayGannon StevenDirectorPPurchase+2.83K$7.99+$22.6K+30.8%12.0K after
Aug 20, 2021 (view filing)Aug 18-192 daysGannon StevenDirectorPPurchase+3.17K$8.05+$25.5K+52.8%9.17K after2 lots
Aug 17, 2021 (view filing)Aug 161 dayGannon StevenDirectorPPurchase+6.00K$8.10+$48.6KNew position6.00K after